Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Atropine Sulfate Min-I-Jet (UCB Pharma)

Atropine Sulfate Min-I-Jet (UCB Pharma) is a medicine containing the active ingredient(s) atropine sulfate monohydrate. On this page you will find out more about Atropine Sulfate Min-I-Jet (UCB Pharma), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: atropine sulfate monohydrate

Over 65 years of age?

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Information for medicine and pack size:
Atropine Sulfate Min-I-Jet (UCB Pharma) 1 mg/10 mL injection solution, 10 mL syringe

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Cardiac: In the management of patients with severe bradyardia and bradyarrhythmias to increase the heart rate. Patients with Type I atrioventricular conduction deficits to lessen the degree of atrioventricular heart block. Anaesthesia: Atropine is indicated as an antisialogogue in anaesthetic premedication to reduce or prevent secretions in the respiratory tract. During anaesthesia, atropine may be used to prevent reflex bradycardia and restore cardiac rate and arterial pressure resulting from the increased vagal activity associated with laryngoscopy, tracheal intubation and intra-abdominal manipulation, and for the prevention of the oculo-cardiac reflex during ophthalmic surgery. It may also be used to block muscarinic effects when neostigmine is used to counter the action of muscle relaxants. Anticholinesterase poisoning: Atropine is indicated in the treatment of cardiovascular collapse following poisoning from cholinesterase inhibitors such as the organophosphorus insecticides parathion and malathion, the nerve gases and from mushroom poisoning

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance Clear, colourless liquid
Dosage Form Injection, solution
Route of administration Intravenous
Medicine schedule
10mL x 1: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Vial
Storage temperature Store below 25 degrees Celsius
Storage conditions Protect from Light
Life time 2 Years
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback